TITLE: Effect of alprazolam (0.5 mg) on driving performance of anxiety patients and healthy controls
AUTHOR: Katerina Touliou, Dr. Evangelos Bekiaris, Dr. Maria Panou
JOURNAL: International Conference on Alcohol, Drugs and Traffic Safety (T2013), 20th, 2013, Brisbane, Queensland, Australia.
ABSTRACT:In the present study the major objective was to investigate the effect of alprazolam in treated
and untreated anxiety patients compared to a
healthy control group after oral alprazolam
administration (0.5 mg) (acute phase) in a simulated environment. Primary variables were the
vehicle variables (driving performance measures). The secondary objective was to compare
multiple cognitive and subjective measures
collected for each participant
in order to establish
the whole range of driving impairment.(Full text here)
MY TAKE:This study demonstrates that a common medication used for anxiety reduces driving performance.